CN108853388A - A kind of preparation of composition and treatment and/or the senile pigment wart of nursing - Google Patents
A kind of preparation of composition and treatment and/or the senile pigment wart of nursing Download PDFInfo
- Publication number
- CN108853388A CN108853388A CN201810914260.8A CN201810914260A CN108853388A CN 108853388 A CN108853388 A CN 108853388A CN 201810914260 A CN201810914260 A CN 201810914260A CN 108853388 A CN108853388 A CN 108853388A
- Authority
- CN
- China
- Prior art keywords
- extract
- wart
- composition
- acid
- nursing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 208000000260 Warts Diseases 0.000 title claims abstract description 62
- 201000010153 skin papilloma Diseases 0.000 title claims abstract description 62
- 239000000049 pigment Substances 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 230000000474 nursing effect Effects 0.000 title claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 115
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims abstract description 40
- -1 podophyllum ester Chemical class 0.000 claims abstract description 34
- 210000000582 semen Anatomy 0.000 claims abstract description 33
- 241001495452 Podophyllum Species 0.000 claims abstract description 31
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 30
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 30
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 30
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000005642 Oleic acid Substances 0.000 claims abstract description 30
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 30
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 30
- VSDNNWKISVRDNT-UHFFFAOYSA-N 2-octoxybenzoic acid Chemical compound CCCCCCCCOC1=CC=CC=C1C(O)=O VSDNNWKISVRDNT-UHFFFAOYSA-N 0.000 claims abstract description 27
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 26
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 26
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 26
- 229940016667 resveratrol Drugs 0.000 claims abstract description 26
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 24
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 24
- 235000010265 sodium sulphite Nutrition 0.000 claims abstract description 20
- 229940001482 sodium sulfite Drugs 0.000 claims abstract description 6
- 241000195955 Equisetum hyemale Species 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 5
- 241000605372 Fritillaria Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000012377 drug delivery Methods 0.000 claims description 3
- 229940040145 liniment Drugs 0.000 claims description 3
- 239000000865 liniment Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 32
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 239000000419 plant extract Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 description 34
- 239000002674 ointment Substances 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 20
- 230000001815 facial effect Effects 0.000 description 10
- 241000701806 Human papillomavirus Species 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000005562 fading Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000037259 Amyloid Plaque Diseases 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 244000166124 Eucalyptus globulus Species 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 2
- 206010059313 Anogenital warts Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 201000003385 seborrheic keratosis Diseases 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000195952 Equisetaceae Species 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- UKTDQTGMXUHPIF-UHFFFAOYSA-N [Na].S(O)(O)=O Chemical compound [Na].S(O)(O)=O UKTDQTGMXUHPIF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000007854 aminals Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The present invention discloses the preparation of a kind of composition and treatment and/or the senile pigment wart of nursing, wherein, the composition includes Rhizoma Bolbostematis extract, Semen Coicis extract, Herba Equiseti Hiemalis extract, folium eucalypti extract, podophyllum ester, oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid and resveratrol.In technical solution provided by the invention, the Rhizoma Bolbostematis extract, Semen Coicis extract, Herba Equiseti Hiemalis extract, folium eucalypti extract and podophyllum ester in the composition are pure natural plant extract, have the characteristics that sore is treated in detoxicating and resolving a mass, expelling pathogenic factors from muscles and skin foster skin, clearing damp, suitable for treating and/or nursing senile pigment wart, with good curative effect, and have no toxic side effect.
Description
Technical field
The present invention relates to the technical field of biological medicine, in particular to a kind of composition and treatment and/or nursing are old
The preparation of property pigment wart.
Background technique
Senile pigment wart (spot), also known as senile wart, senile pigment wart, senile plaque, basal cell papilloma etc.,
It is a kind of most common benign skin tumour of clinic, belongs to epidermis benign proliferative diseases caused by keratinocyte hyperplasia,
It is medically also known as seborrheic keratosis, symptom is to occur a kind of dark brown pigment patch, slightly above skin in old application on human skin
Skin, rough surface can strip off.Senile pigment wart generally often has in face, forehead, back, neck, front etc., sometimes
The exsertion parts such as the back of the hand, upper limb may also be appeared in.Major part is to start discovery after 50 years old to increase, and it is old to be more common in advanced age
People.
The pathomechanism that senile pigment wart (spot) is formed is not yet clear, therefore treats also without specific medicament.At present
Think that the pigment wart of the elderly may be related with peroxide, it is also possible to it is related with immunity degeneration, when general immunity decline,
The resistance of skin also and then reduces;The infection of human papilloma virus (HPV) certain hypotypes may be senile pigment wart
Reason.There are more than 100 kinds of hypotypes due to being currently known human papilloma virus (HPV), part high-risk-type is reported that itself and uterine neck
Cancer morbidity is related, and many other skin benign epidermic hyperplastic tumours (wart or precancerous lesion) are all relevant with HPV, but specific
HPV hypotype is not fully clear.
Recent international scientific literature report, with age, the encoding gene of immune system is carrying out mutation to the mankind
Accumulation, this explains the elderly's pigment warts, the very high reason of verruca plana disease incidence.However, this skin disease of the elderly
Change is usually covered by convention, referred to as " senile plaque ", " senile plaque ", " elderly person for whom a birthday celebration is being held's spot ", " long senile plaque ", so that the elderly oneself passes through
Often ignore, hardly go to see a doctor, Research Literature medically is also fewer and fewer.
With the improvement of the living condition of Chinese, the average life span of compatriots increases quickly, and social aging is more and more
Obviously, the aged is continuously increased, and the cultural quality of the elderly is also continuously improved, to treating or alleviate senile pigment wart (spot)
Demand increase sharply, first is that worrying that the canceration of skin hyperplasia of prostate at cutaneum carcinoma, second is that improving image appearance, improves the old popular feeling
Reason is self-confident and makes mental age rejuvenation, further promotes long-lived.Therefore, it is badly in need of at present a kind of significant in efficacy for treating
And/or the composition or preparation of the senile pigment wart (spot) of nursing.
Summary of the invention
The main object of the present invention is the preparation for proposing a kind of composition and treatment and/or the senile pigment wart of nursing,
Aim to solve the problem that the compound therapeutic effect for being currently used for treating senile pigment wart is bad and there are problems that toxic side effect.
To achieve the above object, the present invention proposes that a kind of composition, the composition include Rhizoma Bolbostematis extract, semen coicis
Extract, Herba Equiseti Hiemalis extract, folium eucalypti extract, podophyllum ester, oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid with
And resveratrol.
Preferably, the composition includes the component of following mass fraction:0.1~5 part of Rhizoma Bolbostematis extract, semen coicis mention
Take 0.1~3 part of object, 0.1~5 part of Herba Equiseti Hiemalis extract, 0.1~5 part of folium eucalypti extract, 0.1~3 part of podophyllum ester, oleic acid 0.1
~5 parts, 0.1~6 part of octyl salicylic acid, 0.1~3 part of sodium sulfite, 0.01~3 part of vitamin A acid and resveratrol 0.1~
5 parts.
Preferably, the composition includes the component of following mass fraction:0.5~3 part of Rhizoma Bolbostematis extract, semen coicis mention
Take 0.3~2.5 part of object, 0.5~3 part of Herba Equiseti Hiemalis extract, 0.5~3 part of folium eucalypti extract, 0.3~2 part of podophyllum ester, oleic acid
0.3~3 part, 0.5~5 part of octyl salicylic acid, 0.3~2 part of sodium sulfite, 0.03~2 part of vitamin A acid and resveratrol
0.5~3 part.
Preferably, the composition includes the component of following mass fraction:2 parts of Rhizoma Bolbostematis extract, Semen Coicis extract
1.5 parts, 1 part of Herba Equiseti Hiemalis extract, 1 part of folium eucalypti extract, 0.6 part of podophyllum ester, 0.6 part of oleic acid, 3 parts of octyl salicylic acid, Asia
1 part of sodium sulphate, 0.06 part of vitamin A acid and 0.8 part of resveratrol.
The present invention also provides a kind of preparations for treating and/or nursing senile pigment wart, including combine as described above
Object.
Preferably, the preparation for treating and/or nursing senile pigment wart is percutaneous drug delivery external preparation.
Preferably, the dosage form of the treatment and/or the preparation for nursing senile pigment wart is emulsion, creme, solution, puts on the skin
Agent, lotion or paste.
In technical solution provided by the invention, the Rhizoma Bolbostematis extract, Semen Coicis extract, Herba Equiseti Hiemalis extract, eucalyptus
Leaf extract and podophyllum ester are pure natural plant extract, have the characteristics that sore is treated in detoxicating and resolving a mass, expelling pathogenic factors from muscles and skin foster skin, clearing damp,
Suitable for treating and/or nursing senile pigment wart, there is good curative effect, and have no toxic side effect.
Specific embodiment
It in order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below will be in the embodiment of the present invention
Technical solution be clearly and completely described.The person that is not specified actual conditions in embodiment, according to normal conditions or manufacturer builds
The condition of view carries out.Reagents or instruments used without specified manufacturer is the conventional production that can be obtained by commercially available purchase
Product.
The present invention provides a kind of composition, can be used for treating senile pigment wart, or assist in the treatment of other pathogenesis
Illness similar with senile pigment wart.The composition includes Rhizoma Bolbostematis extract, Semen Coicis extract, Equisetum hiemale Linne extraction
Object, folium eucalypti extract, podophyllum ester, oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid and resveratrol.Wherein:
The Rhizoma Bolbostematis extract is extracted by the drying stem block of the Chinese medicine rhizoma bolbostemmae, the rhizoma bolbostemmae also known as native shellfish, big fritillaria, it is bitter
Gallbladder or careless shellfish, have effects that removing toxic substances, dissipating bind, detumescence.Separately also there is modern biology the study found that the rhizoma bolbostemmae has suppression
The effect of making the infection of certain HPV viruses.
The Semen Coicis extract is extracted by the dry fruit of Chinese medicine adlay, and the semen coicis is gramineae
Dry mature kernal has clearing damp and promoting diuresis, invigorating the spleen to arrest diarrhea, eliminating impediment, apocenosis, the effect of detoxicating and resolving a mass.Separately also there is modern biology
The study found that the semen coicis has effects that inhibit certain HPV viruse infection.
The Herba Equiseti Hiemalis extract, is the dry aerial parts extract of Equisetaceae plant scouring rush, and the Equisetum hiemale Linne is extracted
Object energy sweating, expelling pathogenic factors from muscles and skin move back screen, and flat sore is swollen hard.Separately also there is modern folk remedy to prompt, the Equisetum hiemale Linne, which has, inhibits certain creams
The effect of head tumor.
The folium eucalypti extract is the full leaf extract of myrtle eucalyptus.The eucalyptus has tourette production of aromatic, removes
It is smelly disinfection, clearing damp heresy effect.Separately also there is modern biology the study found that the folium eucalypti has broad-spectrum antibacterial and anti-corrosion effect.
The podophyllum ester is the extract of sufficient leaf grass or Chinese podophyllum root, according to modern biology the study found that the foot leaf grass
Ester has certain relaxation effect to condyloma acuminatum, wherein the condyloma acuminatum is by a few HPV infection.
The oleic acid is a kind of straight chain list unsaturation Omega-9 fatty acid, is formed in the bodies of aminal and plant that there are many industry
Purposes.The oleic acid is also indispensable nutrient in animal food;The acidity of the oleic acid can promote cuticulated epithelium soft
Change, liposoluble substance is promoted to absorb, moisture of skin is prevented to evaporate, protects cuticula to alleviate oxidative damage.
The octyl salicylic acid is salicylic octyl derivative, has effects that cutin-softening promotes Drug Percutaneous Absorption,
To reinforce the effect of the oleic acid.
The effect of vitamin A acid has and promotes epithelial growth metabolism, and the normal angling of maintenance epithelium is broken up.
The sodium sulfite, with anti-oxidant and bleaching industrial use, in addition, the sodium sulfite is also daily use chemicals license
Additive.
The resveratrol has strength antioxidant effect, can eliminate oxidative damage caused by free radical, has protection
The effect of cell.
It should be noted that the oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid and resveratrol are existing
Product can directly purchase acquisition in the market;The Rhizoma Bolbostematis extract, Semen Coicis extract, Herba Equiseti Hiemalis extract, folium eucalypti mention
It takes object and podophyllum ester equally also for existing product, can directly purchase acquisition in the market, or can also be by from described
Correspondence prepares in the plants such as the rhizoma bolbostemmae, semen coicis, Equisetum hiemale Linne, folium eucalypti and sufficient leaf grass, and specific preparation method can refer to
The prior art is not described further herein.
In technical solution provided by the invention, the Rhizoma Bolbostematis extract, Semen Coicis extract, Herba Equiseti Hiemalis extract, eucalyptus
Leaf extract and podophyllum ester are pure natural plant extract, have the characteristics that sore is treated in detoxicating and resolving a mass, expelling pathogenic factors from muscles and skin foster skin, clearing damp,
Suitable for treating and/or nursing senile pigment wart, there is good curative effect, and have no toxic side effect.
Preferably, in the present embodiment, the composition includes the component of following mass fraction:Rhizoma Bolbostematis extract 0.1
~5 parts, 0.1~3 part of Semen Coicis extract, 0.1~5 part of Herba Equiseti Hiemalis extract, 0.1~5 part of folium eucalypti extract, podophyllum ester
0.1~3 part, 0.1~5 part of oleic acid, 0.1~6 part of octyl salicylic acid, 0.1~3 part of sodium sulfite, 0.01~3 part of vitamin A acid
And 0.1~5 part of resveratrol.
Further, as a preferred embodiment of the invention, the composition includes the component of following mass fraction:
0.5~3 part of Rhizoma Bolbostematis extract, 0.3~2.5 part of Semen Coicis extract, 0.5~3 part of Herba Equiseti Hiemalis extract, folium eucalypti extract
0.5~3 part, 0.3~2 part of podophyllum ester, 0.3~3 part of oleic acid, 0.5~5 part of octyl salicylic acid, 0.3~2 part of sodium sulfite, dimension
Raw 0.03~2 part and 0.5~3 part of resveratrol of element A acid.
Further, as presently most preferred embodiment of the invention, the composition includes the group of following mass fraction
Point:2 parts of Rhizoma Bolbostematis extract, 1.5 parts of Semen Coicis extract, 1 part of Herba Equiseti Hiemalis extract, 1 part of folium eucalypti extract, podophyllum ester
0.6 part, 0.6 part of oleic acid, 3 parts of octyl salicylic acid, 1 part of sodium sulfite, 0.06 part of vitamin A acid and 0.8 part of resveratrol.
The present invention also provides a kind of preparations for treating and/or nursing senile pigment wart, can be used for treating senile pigment
Wart is to alleviate inflammation or the senile pigment wart of nursing to prevent patch appearance, or has both the function for the treatment of and nursing, effectively
Multiple clinical stages suitable for senile pigment wart.Wherein, the preparation for treating and/or nursing senile pigment wart includes
Composition as described above.The treatment and/or to nurse the preparation of senile pigment wart further include Material, for example, be controlled when described
When treating and/or nurse the preparation of senile pigment wart and being specially externally-applied ointment, the Material is externally-applied ointment Material, when described
When the preparation for treating and/or nursing senile pigment wart is face cream, the Material is face cream Material.It needs to illustrate
It is that the preparation of the Material can be found in the prior art, does not repeat herein.It is existing that the composition can be used as additive addition
In the Material, the treatment is made and/or nurses the preparation of senile pigment wart, makes to have and treat senile pigment wart effect
Fruit is good and the advantages of having no toxic side effect.Similarly, the treatment and/or the specific preparation for the preparation for nursing senile pigment wart
Method can refer to the technological means of the existing additive that other treatment function is added for example in ordinary preparation, not go to live in the household of one's in-laws on getting married herein
It states.
The treatment and/or the preparation for nursing senile pigment wart can be diversified forms, but due to the senile color
Plain wart belongs to epidermis benign proliferative diseases, namely is obvious from skin appearance skin, it is therefore preferred that the treatment and/or nursing
The preparation of senile pigment wart is percutaneous drug delivery external preparation, be can be used for coated on affected part to be treated and/or be nursed.
Further, in the present embodiment, the dosage form of the treatment and/or the preparation for nursing senile pigment wart is preferably
Emulsion, creme, solution, liniment, lotion or paste.That is, the preparation treated and/or nurse senile pigment wart
The form of expression can be specifically as follows the skin care milk etc. of the corresponding emulsion dosage form to be a variety of, by taking daily nursing class product as an example;
Correspond to the Essence of the solution dosage form, paste type facial mask etc.;Cold cream, the application type facial mask of the corresponding paste dosage form
Deng.The treatment and/or the preparation for nursing senile pigment wart can also be with the emulsion, creme, solution, liniment, wash
The topical agent that agent or ointment use.It should be noted that the preparation for treating and/or nursing senile pigment wart
Dosage form can also be not limited to above-mentioned dosage form, but be added with the composition, convenient for users to routine use, and have aobvious
The curative effect of the senile pigment wart write, and have no toxic side effect.
Technical solution of the present invention is described in further detail below in conjunction with specific embodiment, it should be understood that following real
It applies example to be only used to explain the present invention, be not intended to limit the present invention.
Embodiment 1
(1) Material of 980g externally-applied ointment is weighed, wherein the Material of the externally-applied ointment includes the component of following quality:
Propylene glycol 100g, 2% sodium hydroxide 60g, albolene 90g, atoleine 200g, octadecyl alcolol 50g, glycerin monostearate
50g, propylparaben 0.5g, menthol 5g, methyl p-hydroxybenzoate 0.5g, stearic acid polyene oxygen rouge 30g and
Distilled water 394g.
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 0.1g, Semen Coicis extract 0.1g, wood
Crafty grass extract 5.13g, folium eucalypti extract 5.13g, podophyllum ester 3.08g, oleic acid 0.1g, octyl salicylic acid 6.15g, sulfurous acid
Sodium 0.1g, vitamin A acid 0.01g and resveratrol 0.1g.
Embodiment 2
(1) Material of 980g externally-applied ointment is weighed, wherein component contained by the Material of the externally-applied ointment and corresponding matter
Amount is referring to embodiment 1;
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 4.1g, Semen Coicis extract 2.46g,
Herba Equiseti Hiemalis extract 0.08g, folium eucalypti extract 0.08g, podophyllum ester 0.08g, oleic acid 4.1g, octyl salicylic acid 0.08g, sulfurous
Sour sodium 2.46g, vitamin A acid 2.46g and resveratrol 4.1g.
Embodiment 3
(1) Material of 980g externally-applied ointment is weighed, wherein component contained by the Material of the externally-applied ointment and corresponding matter
Amount is referring to embodiment 1;
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 3.46g, Semen Coicis extract 2.6g,
Herba Equiseti Hiemalis extract 1.73g, folium eucalypti extract 1.73g, podophyllum ester 1.04g, oleic acid 1.04g, octyl salicylic acid 5.19g, Asia
Sodium sulphate 1.73g, vitamin A acid 0.1g and resveratrol 1.38g.
Embodiment 4
(1) Material of 980g externally-applied ointment is weighed, wherein component contained by the Material of the externally-applied ointment and corresponding matter
Amount is referring to embodiment 1;
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 3.55g, Semen Coicis extract 1.42g,
Herba Equiseti Hiemalis extract 2.84g, folium eucalypti extract 2.12g, podophyllum ester 1.42g, oleic acid 1.42g, octyl salicylic acid 3.55g, Asia
Sodium sulphate 1.13g, vitamin A acid 0.43g and resveratrol 2.12g.
Embodiment 5
(1) Material of 980g externally-applied ointment is weighed, wherein component contained by the Material of the externally-applied ointment and corresponding matter
Amount is referring to embodiment 1;
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 0.68g, Semen Coicis extract 3.42g,
Herba Equiseti Hiemalis extract 0.68g, folium eucalypti extract 4.12g, podophyllum ester 0.41g, oleic acid 0.41g, octyl salicylic acid 0.68g, Asia
Sodium sulphate 2.74g, vitamin A acid 2.74g and resveratrol 4.12g.
Embodiment 6
(1) Material of 980g externally-applied ointment is weighed, wherein component contained by the Material of the externally-applied ointment and corresponding matter
Amount is referring to embodiment 1;
(2) the composition 20g is weighed to mix with the Material of above-mentioned externally-applied ointment, it is outer containing the composition to be made
With ointment, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 3.4g, Semen Coicis extract 0.34g,
Herba Equiseti Hiemalis extract 3.4g, folium eucalypti extract 0.57g, podophyllum ester 2.28g, oleic acid 3.4g, octyl salicylic acid 5.67g, sulfurous
Sour sodium 0.34g, vitamin A acid 0.03g and resveratrol 0.57g.
Embodiment 7
(1) Material of 950g face cream is weighed, wherein the Material of the face cream includes the component of following quality:It is stearic
Sour 57g, stearyl alcohol 17g plus hydrogen lanolin 35g, saualane 78g, 2- octyldodecanol 86g, 1,3-BDO 52g, poly- second
Glycol 1500 35g, POE (25) spermaceti alcohol ether 26g, glycerin monostearate 17g, preservative 3g, antioxidant 43g, fragrance
35g and Purified Water 466g.
(2) it weighs the composition 50g to mix with the Material of above-mentioned face cream, the skin care containing the composition is made
Frost, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 8.64g, Semen Coicis extract 6.48g, scouring rush
Careless extract 4.33g, folium eucalypti extract 4.33g, podophyllum ester 2.6g, oleic acid 2.6g, octyl salicylic acid 12.97g, sodium sulfite
4.33g, vitamin A acid 0.26g and resveratrol 3.46g.
Embodiment 8
(1) Material of 950g facial treatment milk is weighed, wherein the Material of the facial treatment milk includes the component of following quality:
Albolene 86g, octadecyl alcolol 52g, ethylparaben 4g, glycerin monostearate 104g, silicone oil 173g, glycerol 242g, sulfurous
Sour hydrogen sodium 4g, atoleine 120g, sericin 17g and distilled water 148g.
(2) it weighs the composition 50g to mix with the Material of above-mentioned facial treatment milk, the shield containing the composition is made
Skin lotion, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 8.64g, Semen Coicis extract 6.48g,
Herba Equiseti Hiemalis extract 4.33g, folium eucalypti extract 4.33g, podophyllum ester 2.6g, oleic acid 2.6g, octyl salicylic acid 12.97g, sulfurous
Sour sodium 4.33g, vitamin A acid 0.26g and resveratrol 3.46g.
Embodiment 9
(1) Material of 950g facial treatment essence liquid is weighed, wherein the Material of the facial treatment essence liquid includes the group of following quality
Point:Lily polysaccharide 75g, butanediol 110g, cinnamic acid 25g, isopropyl myristate 30g, silicone oil 30g, Sodium Hyaluronate 15g,
Trehalose 25g, antierythrite 20g, xanthan gum 50g, emulsifier 30g, octadecyl alcolol 40g, monoglyceride 30 and deionized water
470g。
(2) it weighs the composition 50g to mix with the Material of above-mentioned facial treatment essence liquid, to be made containing the composition
Facial treatment essence liquid, wherein the composition includes the component of following quality:Rhizoma Bolbostematis extract 8.64g, Semen Coicis extract
6.48g, Herba Equiseti Hiemalis extract 4.33g, folium eucalypti extract 4.33g, podophyllum ester 2.6g, oleic acid 2.6g, octyl salicylic acid
12.97g, sodium sulfite 4.33g, vitamin A acid 0.26g and resveratrol 3.46g.
Embodiment 10
(1) 600g medical ethanol is weighed, wherein the mass concentration of the ethyl alcohol is 95%.
(2) it weighs the composition 400g to compound with the alcohol, the tincture containing the composition is made, wherein
The composition includes the component of following quality:Rhizoma Bolbostematis extract 87.34g, Semen Coicis extract 65.5g, Equisetum hiemale Linne are extracted
Object 43.67g, folium eucalypti extract 43.67g, podophyllum ester 26.2g, oleic acid 26.2g, octyl salicylic acid 26.2g, sodium sulfite
43.67g, vitamin A acid 2.62g and resveratrol 34.93g.
Embodiment 11
(1) matrix of 980g lotion is weighed, wherein the matrix of the lotion includes the component of following quality:Alum 4g,
AES (70%) 52g, DS-600 3g, MES 32g, lanolin 4g, imidazoline 80g, Ninol 22g, GW-901 15g, essence
1g, preservative 1g and deionized water 766g.
(2) the composition 20g is weighed to mix with the matrix of above-mentioned lotion, the lotion containing the composition is made,
Wherein, the composition includes the component of following quality:Rhizoma Bolbostematis extract 3.46g, Semen Coicis extract 2.6g, Equisetum hiemale Linne mention
Take object 1.73g, folium eucalypti extract 1.73g, podophyllum ester 1.04g, oleic acid 1.04g, octyl salicylic acid 5.19g, sodium sulfite
1.73g, vitamin A acid 0.1g and resveratrol 1.38g.
By taking the externally-applied ointment containing the Chinese medicine composition prepared by above-described embodiment 3 as an example, to treatment provided by the invention
The curative effect of the senile pigment wart of the preparation for treating of senile pigment wart is verified, the treatment including clinical case and typical case
Clinical trial, test method and result are as follows:
1, clinical case
(1) case selection:Senile pigment wart patient 100 made a definite diagnosis are selected, wherein male patient 50, female patient
50, the age, the qualification of all patients was almost the same between 40~80 years old, and no significant difference is comparable.
(2) diagnostic criteria:Senile pigment wart is generally mainly in after 40 years old;It is apt to occur in the face of the elderly, the back of the hand, small
Usually on the exposed skin such as leg, instep, trunk;Patch is in brown-black, and patch diameter is generally between 1~10mm, it is also possible to
Reach between 2~3cm;For patch majority not above skin surface, a small number of big spots may also be above skin surface, in flat
Shape;General no conscious sympton occasionally has itch sense of discomfort.
(3) treatment method:When clinical application, daily coating on daytime affected part 3 times, every minor tick 4 hours, after continuing 3 months,
Count clinical efficacy.
(4) efficacy determination:Specific curative effect determinate standard please refers to shown in table 1.
The senile pigment wart efficacy evaluation method of table 1
Curative effect | Clinical symptoms |
Recovery from illness | Macroscopic plaque area fading is greater than 90%, and color disappears substantially |
It is effective | Macroscopic plaque area fading is greater than 60%, and color is obviously thin out |
Effectively | Macroscopic plaque area fading is greater than 30%, and color is visually thin out |
In vain | Macroscopic plaque area fading is less than 10%, and color is without significant change |
(5) treatment results:Specific efficacy result please refers to shown in table 2.
The curative effect statistical result of the senile pigment wart patient of table 2
Effective number (example) | Significant figure (example) | Invalid number (example) | Obvious effective rate (%) | Efficient (%) | |
Patient | 72 | 20 | 8 | 72 | 92 |
By the statistical result in table 2 it is found that the curative effect of the preparation of the senile pigment wart for the treatment of of preparation of the embodiment of the present invention
Significantly, and have no toxic side effect, follow-up is without recurrence.
2, typical case
Case one:Lee, male, 73 years old, Symptoms:There is uneven spot in neck, the back of the hand and back, and big spot is high
Skin out is in flat, brown color.Diagnosis:Belong to typical senile pigment wart.By this implementation of coating during treatment
Externally-applied ointment described in example 3,3 times a day, after 3 months, clinical observation finds macroscopic plaque area fading about 70%, color
It is obvious thin out in light brown.
Case two:Tang, female, 46 years old, Symptoms:At facial two cheeks, forehead, front and the back of the hand there is spot, spot
Point is brown, and biennium spot persistently increases.Diagnosis:Belong to typical senile pigment wart.By this reality of coating during treatment
Externally-applied ointment described in example 3 is applied, 3 times a day, after 1 month, clinical observation finds that macroscopic plaque area fading, color are obvious
It is thin out;After 3 months, clinical observation finds macroscopic plaque area fading about 90%, and color disappears substantially.
In conclusion the preparation of the senile pigment wart for the treatment of provided by the invention, is extracted with Rhizoma Bolbostematis extract, semen coicis
Object, Herba Equiseti Hiemalis extract, folium eucalypti extract, podophyllum ester, oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid and white
Veratryl alcohol prepares for raw material, significant to the therapeutic effect of senile pigment wart, can be taken effect using one month, lasting to use
Effect is obvious, can effective fading senile pigment wart, have no toxic side effect and adverse reaction, and low in cost, be easy to by patient
Receive.
The above is only a preferred embodiment of the present invention, is not intended to limit the scope of the invention, for this field
For technical staff, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any
Modification, equivalent replacement, improvement etc. should all be included within the scope of the present invention.
Claims (7)
1. a kind of composition, which is characterized in that the composition includes that Rhizoma Bolbostematis extract, Semen Coicis extract, Equisetum hiemale Linne mention
Take object, folium eucalypti extract, podophyllum ester, oleic acid, octyl salicylic acid, sodium sulfite, vitamin A acid and resveratrol.
2. composition as described in claim 1, which is characterized in that the composition includes the component of following mass fraction:Soil
0.1~5 part of fritillaria extract, 0.1~3 part of Semen Coicis extract, 0.1~5 part of Herba Equiseti Hiemalis extract, folium eucalypti extract 0.1~5
Part, 0.1~3 part of podophyllum ester, 0.1~5 part of oleic acid, 0.1~6 part of octyl salicylic acid, 0.1~3 part of sodium sulfite, vitamin A
0.01~3 part and 0.1~5 part of resveratrol of acid.
3. composition as claimed in claim 2, which is characterized in that the composition includes the component of following mass fraction:Soil
0.5~3 part of fritillaria extract, 0.3~2.5 part of Semen Coicis extract, 0.5~3 part of Herba Equiseti Hiemalis extract, folium eucalypti extract 0.5
~3 parts, 0.3~2 part of podophyllum ester, 0.3~3 part of oleic acid, 0.5~5 part of octyl salicylic acid, 0.3~2 part of sodium sulfite, dimension life
0.03~2 part of plain A acid and 0.5~3 part of resveratrol.
4. composition as claimed in claim 3, which is characterized in that the composition includes the component of following mass fraction:Soil
2 parts of fritillaria extract, 1.5 parts of Semen Coicis extract, 1 part of Herba Equiseti Hiemalis extract, 1 part of folium eucalypti extract, 0.6 part of podophyllum ester,
0.6 part of oleic acid, 3 parts of octyl salicylic acid, 1 part of sodium sulfite, 0.06 part of vitamin A acid and 0.8 part of resveratrol.
5. a kind for the treatment of and/or the preparation for nursing senile pigment wart, which is characterized in that including such as 1 to 4 any one institute of right
The composition stated.
6. treating and/or nursing as claimed in claim 5 the preparation of senile pigment wart, which is characterized in that the treatment and/
Or the preparation of the senile pigment wart of nursing is percutaneous drug delivery external preparation.
7. treating and/or nursing as claimed in claim 5 the preparation of senile pigment wart, which is characterized in that the treatment and/
Or the dosage form of the preparation of the senile pigment wart of nursing is emulsion, creme, solution, liniment, lotion or paste.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810914260.8A CN108853388A (en) | 2018-08-10 | 2018-08-10 | A kind of preparation of composition and treatment and/or the senile pigment wart of nursing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810914260.8A CN108853388A (en) | 2018-08-10 | 2018-08-10 | A kind of preparation of composition and treatment and/or the senile pigment wart of nursing |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108853388A true CN108853388A (en) | 2018-11-23 |
Family
ID=64317470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810914260.8A Pending CN108853388A (en) | 2018-08-10 | 2018-08-10 | A kind of preparation of composition and treatment and/or the senile pigment wart of nursing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853388A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258530A (en) * | 1998-12-31 | 2000-07-05 | 甘肃省医学科学研究院 | Liniment for treating skin wart, infectious soft wart and senile wart |
-
2018
- 2018-08-10 CN CN201810914260.8A patent/CN108853388A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258530A (en) * | 1998-12-31 | 2000-07-05 | 甘肃省医学科学研究院 | Liniment for treating skin wart, infectious soft wart and senile wart |
Non-Patent Citations (2)
Title |
---|
徐文峰等: "《常见病自我诊疗》", 31 May 2003, 广州出版社 * |
马振友等: "《皮肤美容化妆品制剂手册》", 31 January 2015, 中医古籍出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10864240B2 (en) | Pharmaceutical composition for treating skin wounds and a method of treating skin wounds using thereof | |
CN106580797A (en) | Whitening and freckle-removing cream and preparation method thereof | |
US20190151232A1 (en) | Topical Compositions, Process of Manufacture and Method of Use | |
WO2013000382A1 (en) | Fatty acid composition and plant extract and pharmaceutical preparation and application thereof | |
US11564963B2 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
US20200276256A1 (en) | Skin care composition | |
CN113520896A (en) | Composition with acne removing and acne mark repairing functions and preparation method thereof | |
KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
KR101187683B1 (en) | Antifungal composition comprising herb extracts, Anti-dermatophytosis by using thereof and, method of manufacturing thereof | |
KR101033921B1 (en) | Composition for reducing irritation and inflammation in skin | |
EP4153321A1 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
KR20210072966A (en) | Nanocapsule composition for skin moisturizing or skin inflammatory improvement comprsing encapsulated centella and calamine | |
KR20130089045A (en) | Composition containing bee venom and propolis for preventing or treating acne | |
KR101950331B1 (en) | Compositions for decreasing sebum and improving acne comprising extracts of Pinus densiflora leaf, Artemisia annua and Citrus junos fruit | |
CN108853388A (en) | A kind of preparation of composition and treatment and/or the senile pigment wart of nursing | |
US11903987B2 (en) | Artificial compositions comprising corosolic acid, oleanolic acid; and ursolic acid in a form of an emulsion, salve, ointment, suspension, or gel | |
US20200085959A1 (en) | Cannabinoid and Terpene-Infused Topical Cream | |
Lavanya et al. | Aloe vera on skin. | |
KR20210044762A (en) | Anti-microbial composition comprising pinus koraiensis sieb extract | |
KR20130032420A (en) | Composition for external application to the skin using an extract of seeds of opuntia ficus-indica var. saboten | |
US9421235B2 (en) | Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient | |
Naser et al. | Plants Extract Oils and Their Antimicrobial Activity in Treatment of Denture Stomatitis: Lemongrass Essential Oil (A review of literature) | |
CN110652533A (en) | Antibacterial composition and application thereof | |
CN107714834A (en) | A kind of composition of camellia oil preparation for external use, preparation method and applications | |
CN115671239B (en) | Anti-inflammatory, detumescence, antibacterial, antipruritic, anticracking and repairing jelly-curing cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181123 |